May 21, 2024 — Anumana, a Cambridge, MA-based artificial intelligence (AI)-driven health technology company and portfolio company of nference, has announced it has received the International Organization for Standardization (ISO) 13485 certification for its Quality Management System. 

May 21, 2024 — Stereotaxis, a pioneer and global leader in surgical robotics for minimally invasive endovascular intervention, today announced that it has

May 21, 2024 — A new research paper was published in Aging (listed by MEDLINE/PubMed as "Aging (Albany NY)" and "Aging-US" by Web of Science) Volume 16, Issue 8, entitled, “Associations among NMR-measured inflammatory and metabolic biomarkers and accelerated aging in cardiac catheterization patients.”

May 20, 2024 — Ochsner Medical Center - Baton Rouge has earned The Joint Commission’s Gold Seal of Approval and the American Stroke Association’s Heart-Check mark for Acute Stroke Ready Certification. 

The designation means OMC-Baton Rouge meets The Joint Commission's designation for readiness to treat patients who experience severe stroke.  

May 20, 2024 — Cardiologist Brendan Carry, MD, and a team of Danville, PA-based Geisinger Medical Center physicians have enrolled the first patient in the U.S. into a cardiac amyloidosis trial. The team is also the first to in the U.S. to screen for the trial.

May 19, 2024 — A physician-initiated prospective, randomized clinical trial sponsored by the National Heart, Lung, and Blood Institute (NHLBI) found that early cardiac resynchronization therapy (CRT) may slow the progression of heart failure in patients with mild to moderately reduced left ventricular ejection fraction (LVEF) and left bundle branch block (LBBB).

May 18, 2024 — Boston Scientific Corporation today announced positive six-month results from the ongoing pivotal MODULAR ATP clinical trial of the

May 18, 2024 — The Heart Rhythm Society (HRS) has announced the findings of three new studies demonstrating the safety and efficacy of pulsed field ablation (PFA), a nonthermal ablation treatment for patients with atrial fibrillation (AFib).

May 17, 2024 — Royal Philips, a global leader in health technology, is presenting new retrospective study results demonstrating the clinical and economic benefits of Philips’ AI-powered cardiac care solutions at the

May 17, 2024 — The study design and baseline characteristics of FINE-HEART, a new prespecified, exploratory pooled analysis of three Phase III trials with finerenone1, were presented today as a Late-Breaking Science Session at

Subscribe to
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now